Molecular and biological interactions between two HIV-1 strains from a coinfected patient reveal the first evidence in favor of viral synergism

Virology

Volumn 274, Issue 1, 2000, Pages 105-119

  Wang, Bin ^a   Lal, Renu B ^b   Dwyer, Dominic E ^c   Miranda Saksena, Monica ^a   Boadle, Ross ^c   Cunningham, Anthony L ^a   Saksena, Nitin K ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MOLECULAR INTERACTION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIROGENESIS; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034663129     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0402     Document Type: Article

References (54)

1. CC CKR5: A RANTES, MlP-1 alpha, MlP-1 beta receptor as a fusion cofactor for macrophagetropic HIV-1
2. Recovery of infectious human immunodeficiency virus type 1 after fusion of defectively infected clones of U-937 cells
3. Dual infection with different strains of the same HIV-1 subtype
4. Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand
5. Genetic recombination of human immunodeficiency virus
6. Genetic variation in AIDS viruses
7. Identification of a major co-receptor for primary isolates of HIV-1
8. Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient
9. PHYLIP. Phylogeny Inference Package (Version 3.2)
10. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
11. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule
12. Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: Evidence for in vivo recombination and determinants of cytotropism outside the V3 domain
13. Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS
14. CLUSTAL V: Improved software for multiple sequence alignment
15. HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ co-receptors
16. Retroviral recombination and reverse transcription
17. Analysis of critical domain in the V3 loop of human immunodeficiency virus type-1 gp120 involved in CCR5 utilization
18. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
19. Mosaic genome structure of simian immunodeficiency virus from west African green monkeys
20. Recombinant interleukin 4 stimulates human immunodeficiency virus production by infected monocytes and macrophages
21. Retroviral recombination can lead to linkage of reverse transcriptase mutations that confer increased zidovudine resistance
22. Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5
23. HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad
24. A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as co-receptors with CD4
25. Change in tropism upon immune escape by human immunodeficiency virus
26. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations
27. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in co-receptor usage
28. Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure
29. Tenth anniversary perspectives on AIDS. HIV: Between past and future
30. Genetically divergent strains of human immunodeficiency virus type 2 use multiple co-receptors for viral entry
31. Co-receptor usage of BOB/GPR15 and Bonzo/STRL33 by primary isolates of human immunodeficiency virus type 1
32. Fidelity of HIV-1 reverse transcriptase
33. Mixed human immunodeficiency virus (HIV) infection in an individual: Demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction
34. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
35. The accuracy of reverse transcriptase from HIV-1
36. Recombination in HIV-1
37. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil
38. The neighbor-joining method: A new method for reconstructing phylogenetic trees
39. Coinfection and genetic recombination between HIV-1 strains: Possible biological implications in Australia and South East Asia
40. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene
41. In vivo sequence changes of HIV-1 envelope V2 and V3 loops
42. Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate
43. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
44. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1
45. Molecular analyses of human immunodeficiency virus type 1 V3 region quasispecies derived from plasma and peripheral blood mononuclear cells of the first long-term nonprogressing mother and child pair
46. A unique, naturally occurring single-amino acid mutation in HIV type 1 V3 loop can discriminate between its cytopathicity and replication in vivo and in vitro
47. Molecular mechanisms of variation in influenza viruses
48. Extensive diversification of human immunodeficiency virus type 1 subtype B strains during dual infection of a chimpanzee that progressed to AIDS
49. The antigenic structure of HIV gp120 envelope glycoprotein
50. CCR5 co-receptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: Delineation of consensus motif in the V3 domain that predicts CCR-5 usage
51. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1
52. Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users
53. HIV-1 acquires resistance to two classes of antiviral drugs through homologous recombination
54. Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor